FINDLAY, OH - January 20, 2026 - PRESSADVANTAGE - Dr. Andrea Adams-Miller of TheREDCarpetConnection.com, LLC, reacts to ...
Scientists still don’t know how the brain turns physical activity into thoughts, feelings, and awareness—but a powerful new tool may help crack the mystery. Researchers at MIT are exploring ...
A measure of brain complexity, derived from magnetic stimulation and EEG, can effectively evaluate conscious processing in ...
A popular technique for studying brain disorders, known as lesion network mapping (LNM), appears to have a fundamental ...
– Issued and pending claims expected to protect ALTO-207 into the mid-2040s – MOUNTAIN VIEW, Calif., January 14, 2026--(BUSINESS WIRE)--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage ...
MOUNTAIN VIEW, Calif. - Alto Neuroscience, Inc. (NYSE:ANRO) announced the issuance of U.S. Patent Number 12,521,374 covering methods of treating depression with ALTO-207, a novel combination of ...
– Issued and pending claims expected to protect ALTO-207 into the mid-2040s – The company believes that, together with previously issued patents and pending applications in the U.S. and ...
(MENAFN- GlobeNewsWire - Nasdaq) FINDLAY, OH, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Dr. Andrea Adams-Miller of TheREDCarpetConnection, LLC, reacts to the increase in cold and flu activity across the ...
– Issued and pending claims expected to protect ALTO-207 into the mid-2040s – Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of ...
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results